ATE364706T1 - Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden - Google Patents

Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden

Info

Publication number
ATE364706T1
ATE364706T1 AT98964170T AT98964170T ATE364706T1 AT E364706 T1 ATE364706 T1 AT E364706T1 AT 98964170 T AT98964170 T AT 98964170T AT 98964170 T AT98964170 T AT 98964170T AT E364706 T1 ATE364706 T1 AT E364706T1
Authority
AT
Austria
Prior art keywords
mammastatin
kda
phosphorylated
mammary
express
Prior art date
Application number
AT98964170T
Other languages
English (en)
Inventor
Paul Ervin
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE364706T1 publication Critical patent/ATE364706T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98964170T 1997-12-19 1998-12-18 Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden ATE364706T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/994,076 US6500937B1 (en) 1996-10-03 1997-12-19 Nucleotide sequence encoding a mammary cell growth inhibitor

Publications (1)

Publication Number Publication Date
ATE364706T1 true ATE364706T1 (de) 2007-07-15

Family

ID=25540260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98964170T ATE364706T1 (de) 1997-12-19 1998-12-18 Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden

Country Status (8)

Country Link
US (5) US6500937B1 (de)
EP (1) EP1037989B1 (de)
JP (1) JP4441113B2 (de)
AT (1) ATE364706T1 (de)
AU (1) AU1935399A (de)
CA (1) CA2315239C (de)
DE (1) DE69837935T2 (de)
WO (1) WO1999032625A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0929675A2 (de) * 1996-10-03 1999-07-21 Biotherapies, Inc. Nukleotid- und proteinsequenz von mammastatin und verfahren zu deren anwendung
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
BR0012301A (pt) * 1999-06-18 2002-03-26 Biotherapies Inc Inibidores de crescimento de células epiteliais
US6939714B2 (en) 1999-06-18 2005-09-06 Biotherapies, Inc. Epithelial cell growth inhibitors
EP1208381A2 (de) * 1999-08-13 2002-05-29 Oxford GlycoSciences (UK) Limited Verfahren zum nachweis von brustkrebs
WO2001046697A2 (en) * 1999-12-21 2001-06-28 Millennium Predictive Medicine Identification, assessment, prevention, and therapy of breast cancer
WO2001071357A2 (en) * 2000-03-20 2001-09-27 Oxford Glycosciences (Uk) Limited Diagnosis and treatment of breast cancer
US20030212263A1 (en) * 2000-06-19 2003-11-13 The University Of Michigan Mammastatin sequence variant C
EP1384079A2 (de) * 2001-05-02 2004-01-28 Oxford GlycoSciences (UK) Limited Proteinen, genen und ihre verwendung zur diagnose und behandlung von brustkrebs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379839A (en) 1977-05-23 1983-04-12 The Trustees Of Columbia University In The City Of New York Method for detecting cancer
US4753894A (en) 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
WO1989011491A1 (en) 1988-05-20 1989-11-30 The Regents Of The University Of Michigan Antibodies to human mammary cell growth inhibitor and methods of production and use
WO1989011492A1 (en) 1988-05-20 1989-11-30 The Regents Of The University Of Michigan Human mammary cell growth inhibitor and methods of production and use
US5878385A (en) * 1996-09-16 1999-03-02 Ergo Linguistic Technologies Method and apparatus for universal parsing of language
EP0929675A2 (de) * 1996-10-03 1999-07-21 Biotherapies, Inc. Nukleotid- und proteinsequenz von mammastatin und verfahren zu deren anwendung
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
BR0012301A (pt) 1999-06-18 2002-03-26 Biotherapies Inc Inibidores de crescimento de células epiteliais

Also Published As

Publication number Publication date
US6500937B1 (en) 2002-12-31
JP4441113B2 (ja) 2010-03-31
WO1999032625A2 (en) 1999-07-01
JP2001526891A (ja) 2001-12-25
EP1037989B1 (de) 2007-06-13
US7816097B2 (en) 2010-10-19
CA2315239A1 (en) 1999-07-01
US20110003318A1 (en) 2011-01-06
US7256277B2 (en) 2007-08-14
US20080207506A1 (en) 2008-08-28
WO1999032625A3 (en) 1999-09-16
EP1037989A2 (de) 2000-09-27
DE69837935D1 (de) 2007-07-26
US20070082334A1 (en) 2007-04-12
DE69837935T2 (de) 2008-02-21
CA2315239C (en) 2008-05-13
US6599495B1 (en) 2003-07-29
AU1935399A (en) 1999-07-12

Similar Documents

Publication Publication Date Title
DE69131580D1 (de) GDF-1 und UOG1 Proteine
EP0653940A4 (de) Glialmitogene faktoren, ihre herstellung und verwendung.
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
AR001731A1 (es) Nueva celulasa método para producirla composición que la contiene vector que comprende al adn que lacodifica celula huesped método de aplicación
ATE328095T1 (de) Verbesserungen des stärkegehaltes von pflanzen
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
AU6589094A (en) 7-deazapurine modified oligonucleotides
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
NZ510356A (en) Molecules designated LDCAM
DE68910279D1 (de) Hydroxyfunktionelle Monomere, ihre Herstellung sowie ihre Verwendung zur Herstellung von Polyurethanen.
ATE364706T1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
ATE384787T1 (de) Tripeptidyl-aminopeptidase
NO853012L (no) Nye genetiske sekvenser, interfenonpeptider av type i uttrykt av disse og organismer som produserer dem.
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
DE68902192D1 (de) Ethylenthioharnstoff enthaltende zusammensetzungen zur herstellung von verschleissfesten, stromlos abgeschiedenen nickel-borueberzuegen.
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
WO1998014577A3 (en) Nucleotide and protein sequence of mammastatin and methods of use
ATE214427T1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
WO1990007321A3 (en) Lymphocyte receptor homing sequences and their uses
NO20003146L (no) Ketonperoksyd-derivater, deres fremstilling og anvendelse
EP1163373A4 (de) Antisense-modulation des zellulären hemmstoffs der apoptosis-expression
WO2000008157A3 (en) Human anion transporter genes atnov
ATE302215T1 (de) Modulatoren von intrazellulären entzündungs-, zelltod- und zellüberlebenswegen, die card- und kinase-domänen enthalten
FI902803A7 (fi) DNA-sekvenssi, joka koodaa a-amylaasi-pullulanaasientsyymiä

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties